Clinical trials: HDL Cholesterol
Disbiosis, Obesity
Limosilactobacillus Fermentum CRL 1446 - CONICET CASASCO
This research study aims to determine if a probiotic called Limosilactobacillus fermentum CRL 1446 can improve the health of people at risk for cardiovascular disease.
- Conditions
- Disbiosis, Obesity, Overweight (BMI > 25), Hypertension (Without Type 2 Diabetes Mellitus)
- Trial name
- NCT07530575
- Testing
- Limosilactobacillus fermentum 1446 CRL CONICET 2.20E+9 CFU
- Where
- 2 sites in Argentina
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- PINER Pastor Manfredi Winery
Cholesterol, Cholesterol (total and HDL)
Natural Heart Health Supplement Trial
We are running a 3-month trial of an experimental natural heart health supplement. Participants will take a daily dose of an experimental natural heart health supplement in powdered format, chocolate flavor.
- Trial name
- NCT06671769
- Testing
- Heart Health Supplement
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Efforia, Inc
HDL Cholesterol
A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)
The purpose of this study is to see how well simvastatin raises HDL levels in patients with Type 2 Diabetes.
- Trial name
- NCT00389896
- Testing
- MK0733 / Duration of Treatment: 18 Weeks
- Volunteers
- 150 people
- Sponsor
- Organon and Co
Diabetic Patients, Low HDL-cholesterol (< 35 mg/dL)
DLBS1449 in Diabetic Patients With Low HDL
This is a parallel, 3-arm, randomized, prospective, placebo-controlled, and double-blind clinical study for eight weeks of therapy to investigate the clinical efficacy of DLBS1449 in elevating high density lipoprotein (HDL)…
- Conditions
- Diabetic Patients, Low HDL-cholesterol (< 35 mg/dL), Lifestyle Intervention for at Least 1 Month
- Trial name
- NCT01972477
- Testing
- DLBS1449
- Where
- Indonesia
- Sponsor
- Dexa Medica Group
HDL Cholesterol
Effect of Niaspan on Cholesterol in Men
To determine whether 8 weeks of Niaspan treatment increases cholesterol efflux in male subjects with low HDL-C cholesterol when compared to no treatment.
- Trial name
- NCT00765284
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- KineMed